.RESEARCH STUDY EMPHASIZE.06 August 2024.
A sizable randomized measured test along with cisgender women highlights the difficulties of fidelity to a day-to-day oral preexposure treatment program as well as illustrates that twice-yearly treatment of lenacapavir may keep successful HIV protection levels over 6 months.